the effect of consuming rice husk and rice bran on weight loss
Not Applicable
- Conditions
- Condition 1: obesity. Condition 2: overweight.Obesity due to excess caloriesObesity, unspecified
- Registration Number
- IRCT2015040721652N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
healthy men and women 20–50 years with BMI>25; stable weight for more than 6 months; low physical activity. Exclusion criteria: hormone therapy; taking supplements; lipid-lowering medication; weight-lowering medication; smoking; alcoholism; major illnesses (including diabetes mellitus; chronic renal failure; uncontrolled hypertension (>180/100 mm Hg)); Iron deficiency; pregnancy/ lactation; fiber allergies; using low caloric diet at 6 months; reporting a weight change of 5 kg during the previous 6 months; heavy physical activity.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: Seca scale.;Waist circumference. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: nonstretchable tape measure.
- Secondary Outcome Measures
Name Time Method Total cholestrol. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: autoanalyzer bt1500.;Triglycerides. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: autoanalyzer bt1500.;HDL- cholestrol. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: autoanalyzer bt1500.;LDL-cholestrol. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: autoanalyzer bt1500.;CRP. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: ELISA.;IL-6. Timepoint: at baseline and at 12 weeks following end of intervention. Method of measurement: colorimetry.